Shanghai Saierxin Biomedical Technology Co., Ltd. Has Collaborated With Professor Yisong Wan From The University Of North Carolina In The Research Of Tregs
In March 2023, Shanghai Saierxin Biomedical Technology Co., Ltd. (NOVABIOTX) and Professor Yisong Wan of the University of North Carolina in the United States announced an important collaboration aimed at deepening the exploration of regulatory T cells (Tregs) in the immune system and promoting their industrialization process.
Treg cells are a special type of immune cells that play a crucial role in maintaining immune balance and self-immune regulation. Understanding the function and regulatory mechanisms of Treg cells is critical for the treatment of diseases and the development of immunotherapy. Professor Wan is a well-known expert in the field of Tregs and his research is highly regarded worldwide.
NOVABIOTX is an innovative enterprise specialized in biotechnology research and drug development, with a mission to develop new treatment methods to improve patients’ quality of life. Collaborating with Professor Wan will enable us to better understand the biological characteristics of Treg cells and provide a solid scientific foundation for the development of new therapies.
Professor Wan stated, “Research on Treg cells has always been of great interest, and this collaboration will provide us with a unique opportunity to accelerate our understanding of these cells and bring innovation to future immunotherapy.”
This collaboration will combine NOVABIOTX expertise with Professor Wan’s professional knowledge to jointly explore the function, regulatory mechanisms, and potential therapeutic applications of Tregs, promoting progress in biomedical research and biotechnology innovation.
About NOVABIOTX
NOVABIOTX is an enterprise specializing in biotechnology research and drug development, dedicated to providing innovative medical solutions for patients. The company’s mission is to improve patients’ quality of life, especially those in need of new treatment methods, through scientific research and innovation.
Left: Dr. Mingqi Lu, CEO of NOVABIOTX. Right: Professor Yisong Wan from the University of North Carolina.